Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.4.1.16: chitin synthase

This is an abbreviated version!
For detailed information about chitin synthase, go to the full flat file.

Word Map on EC 2.4.1.16

Reaction

UDP-N-acetyl-alpha-D-glucosamine
+
[(1->4)-N-acetyl-beta-D-glucosaminyl]n
=
UDP
 +
[(1->4)-N-acetyl-beta-D-glucosaminyl]n+1

Synonyms

AaCHS-1, acetylglucosaminyltransferase, chitin-uridine diphosphate, AgCHS-1, AgCHS-2, Ar-CS1, BcChsVI, BmCHSA-2a, BmCHSA-2b, CaChs1, CaChs2p, chitin synthase 1, chitin synthase 2, chitin synthase 3, chitin synthase 3a, chitin synthase 4, chitin synthase 5, chitin synthase 6, chitin synthase 7, chitin synthase A, chitin synthase B, chitin synthase II, chitin synthase III, chitin synthase protein 2, chitin synthetase, chitin synthetase I, chitin synthetase II, chitin synthetase III, chitin-UDP acetyl-glucosaminyl transferase 1, chitin-UDP acetyl-glucosaminyl transferase 2, chitin-UDP acetyl-glucosaminyl transferase 3, chitin-UDP acetyl-glucosaminyl transferase 4, chitin-UDP acetyl-glucosaminyl transferase 5, chitin-UDP acetyl-glucosaminyl transferase 6, chitin-UDP acetyl-glucosaminyl transferase 7, chitin-UDP N-acetylglucosaminyltransferase, chitin-uridine diphosphate acetylglucosaminyltransferase, CHS, CHS B, chs-1, chs-2, CHS-3, CHS-6, Chs1, CHS1a, CHS1b, CHS1p, Chs2, CHS2p, CHS3, CHS3a, Chs3p, CHS4, Chs4p, CHS5, CHS6, CHS7, Chs8, chsA, chsB, chsC, chsE, CHSI, CHSIIIa, CHSIIIb, class A chitin synthase, class I CHS, class IV CaChs3p, class IV chitin synthase, class IV CHS, class V chitin synthase, class Vb chitin synthase, class VII chitin synthase, class-A CHS, class-B CHS, class-II chitin synthase 1, CSI, CSII, CSIII, CsmA, CsmB, DmCHS-1, DmCHS-2, DmeChSB, EhCHS-1, EhCHS-2, LcCHS-1, LeChs1, LsCHS-1, Mcs1, More, MsCHS-1, MsCHS1, MsCHS2, myosin motor-like chitin synthase, Ov-chs-2, PdChsVII, TcCHS1, TcCHS2, trans-N-acetylglucosaminosylase, UDP-GlcNAc:chitin 4-alpha-N-acetylglucosaminyltransferase, UmCHS3, UmCHS6, WdCHS1, WdChs3p, WdChs5p

ECTree

     2 Transferases
         2.4 Glycosyltransferases
             2.4.1 Hexosyltransferases
                2.4.1.16 chitin synthase

Inhibitors

Inhibitors on EC 2.4.1.16 - chitin synthase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(2R,3R,4R,5R)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
-
IC50: 1.6 mM
(2R,3R,4R,5S)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
-
IC50: 38 mM
(2S,3R,4R,5R)-2-[(1-ethylphosphonyl)-1,1-difluoromethyl]-3,4-dihydroxy-5-hydroxymethyl-pyrrolidine
-
IC50: 4.0 mM
1-(2,2-dibutyl-5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-3(2H)-yl)ethanone
-
0.25 mM, about 30% residual activity
1-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetyl)pyrrolidine-2-carboxylic acid
-
75.5% inhibition at 0.3 mg/ml
1-Geranyl-2-methylbenzimidazole
-
weak
1-[2,2-dibutyl-5-(2-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 10% residual activity
1-[2,2-dibutyl-5-(4-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 30% residual activity
1-[2,2-dibutyl-N-[(2,6-difluorophenyl)carbonyl]-5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 20% residual activity
1-[2,2-dibutyl-N-[(2-chlorophenyl)carbonyl]-5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 15% residual activity
1-[2,2-dibutyl-N-[(2-chlorophenyl)carbonyl]-5-(3,5-dimethylphenyl)-1,3,4-oxadiazol-3(2H)-yl]ethanone
-
0.25 mM, about 25% residual activity
2,2'-methylenebis(3,4,6-trichlorophenol)
-
0.25 mM, 56% inhibition
2,3,5,6-Tetrachloro-4-methoxyphenol
-
0.25 mM, 48% inhibition
2,5-dideoxy-2,5-imino-D-glucitol
-
IC50: 5.7 mM
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N,N-dipropylacetamide
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(2-nitrophenyl)acetamide
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(3-nitrophenyl)acetamide
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(4-(trifluoromethyl)phenyl)acetamide
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(4-methoxyphenyl)acetamide
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(4-nitrophenyl)acetamide
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-(ptolyl)acetamide
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-methyl-N-phenylacetamide
-
-
2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)-N-phenylacetamide
-
-
2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)-3-(4-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetoxy)phenyl)propanoic acid
-
65.3% inhibition at 0.3 mg/ml
2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)-3-phenylpropanoic acid
-
-
2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)-4-(methylthio)butanoic acid
-
-
2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)acetic acid
-
-
2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)butanoic acid
-
-
2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)propanoic acid
-
-
3,5-Dichloro-4-methoxybenzaldehyde
-
0.25 mM, 17% inhibition
3,5-Dichloro-4-methoxybenzyl alcohol
-
0.25 mM, 40% inhibition
3,5-Dichlorobenzyl alcohol
-
0.25 mM, 15% inhibition
3-(1H-imidazol-5-yl)-2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)propanoic acid
-
61.5% inhibition at 0.3 mg/ml
3-(1H-indol-3-yl)-2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)propanoic acid
-
-
3-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)propanoic acid
-
-
3-(2-hydroxy-3-(methyl(2-oxo-2-(piperidin-1-yl)ethyl)amino)propyl)-1-methylquinazoline-2,4(1H,3H)-dione
-
-
3-hydroxy-2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)propanoic acid
-
-
3-methyl-2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)butanoic acid
-
-
4-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)butanoic acid
-
68.2% inhibition at 0.3 mg/ml
4-methyl-2-(2-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetamido)pentanoic acid
-
-
5'-(N-succinyl)-5'-amino-5'-deoxyuridine
-
-
-
5'-(N-succinyl)-5'-amino-5'-deoxyuridine methyl ester
-
inhibits the yeast enzyme, and exhibits synergistic interaction with caspofungin against Candida albicans
-
5'-(N-succinylglycyl)-5'-amino-5'-deoxyuridine
-
-
5'-(N-succinylglycyl)-5'-amino-5'-deoxyuridine methyl ester
-
-
5'-deoxy-5'-(glycylamino)uridine
-
-
-
5-(4-(2-hydroxy-3-((2-methoxyphenyl)amino)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-((4-methoxyphenyl)amino)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(1H-imidazol-1-yl)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(4H-1,2,4-triazol-4-yl)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(naphthalen-1-ylamino)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(o-tolylamino)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(p-tolylamino)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(phenylamino)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(piperazin-1-yl)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(piperidin-1-yl)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-(pyrrolidin-1-yl)propyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(2-hydroxy-3-morpholinopropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-((2,6-dimethylphenyl)amino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-((2-chlorophenyl)amino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-((4-bromophenyl)amino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-((4-chlorobenzyl)amino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-((4-chlorophenyl)amino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-(azepan-1-yl)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-(benzylamino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-(bis(2-hydroxyethyl)amino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-(butylamino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-(diethylamino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-(4-(3-(tert-butylamino)-2-hydroxypropyl)piperazin-1-yl)-2-oxo-1,2,3,4-tetrahydroquinoline hydrochloride
-
-
5-[(3,6,6-trimethylhept-4-yn-1-yl)amino]quinolin-2(1H)-one
-
-
5-[(6,6-dimethylhepta-2,4-diyn-1-yl)(methyl)amino]-3,4-dihydroquinolin-2(1H)-one
-
-
8,20-dihydroxy-9(11),13-abietadien-12-one
8-[(6,6-dimethylhepta-2,4-diyn-1-yl)(methyl)amino]-2H-1,4-benzoxazin-3(4H)-one
-
-
AMP
-
6.25 mM
amphotericin
-
noncompetitive
Amphotericin B methyl ester
-
-
Ba2+
-
10 mM, 61% inhibition
bis(5'-amino-5'-deoxyuridine) 2,2'-[(1,4-dioxobutane-1,4-diyl)diazanediyl]diacetate
-
50% inhibition at 3 mM
bis(5'-amino-5'-deoxyuridine) 4-[(carboxymethyl)amino]-4-oxobutanoate
-
-
bis(5'-amino-5'-deoxyuridine) succinate
-
-
c3',5'-AMP
-
2 mM, slight inhibition
Calcofluor white
-
noncompetitive
Captan
Cd2+
-
complete inhibition of wild-type and mutant enzymes
chitin oligosaccharides
-
slight
chitodextrins
-
-
-
Cl-
-
10 mM
Diflubenzuron
edifenphos
-
non-competitive
Filipin
-
weak
Hexachlorophene
-
inhibition can be reversed by lecithin
insecticidal benzoylphenyl ureas
-
-
-
itraconazole
-
-
K+
-
10 mM, 14% inhibition
kanakugiol
-
inhibition of chitin synthase 2 and antifungal activity of the lignan from the stem bark of Lindera erythrocarpa, overview
linderone
-
inhibition of chitin synthase 2 and antifungal activity of the lignan from the stem bark of Lindera erythrocarpa, overview
methyl 2-((2-(methyl(2-oxo-2H-chromen-4-yl)amino)ethoxy) (phenoxy)phosphorylamino)-3-phenylpropanoate
-
-
methyl 2-((2-(methyl(2-oxo-2H-chromen-4-yl)amino)ethoxy) (phenoxy)phosphorylamino)acetate
-
-
methyl 2-((2-(methyl(2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate
-
-
methyl 2-((2-(methyl(6-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate
-
-
methyl 2-((2-(methyl(6-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)acetate
-
-
methyl 2-((2-(methyl(6-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate
-
-
methyl 2-((2-(methyl(6-tert-butyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate
-
a noncompetitive inhibitor against chitin synthase
methyl 2-((2-(methyl(6-tert-butyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)acetate
-
-
methyl 2-((2-(methyl(6-tert-butyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate
-
-
methyl 2-((2-(methyl(7-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate
-
-
methyl 2-((2-(methyl(7-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-acetate
-
-
methyl 2-((2-(methyl(7-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate
-
-
methyl 2-((2-(methyl(8-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-3-phenylpropanoate
-
-
methyl 2-((2-(methyl(8-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)-acetate}
-
-
methyl 2-((2-(methyl(8-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)propanoate
-
-
methyl 2-(2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamido)benzoate
-
-
methyl 3-methyl-2-((2-(methyl(2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate
-
-
methyl 3-methyl-2-((2-(methyl(6-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate
-
-
methyl 3-methyl-2-((2-(methyl(6-tert-butyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate
-
-
methyl 3-methyl-2-((2-(methyl(7-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate
-
-
methyl 3-methyl-2-((2-(methyl(8-methyl-2-oxo-2H-chromen-4-yl)amino)ethoxy)(phenoxy)phosphorylamino)butanoate
-
-
methyllinderone
-
inhibition of chitin synthase 2 and antifungal activity of the lignan from the stem bark of Lindera erythrocarpa, overview
N,N'-diacetylchitobiose
-
-
N,N-dibenzyl-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl) (methyl) amino)acetamide
-
-
N,N-diethyl-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl) (methyl) amino)acetamide
-
-
N- benzyl-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl) amino)acetamide
-
-
N-(2-chlorophenyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide
-
-
N-(4-(cyanomethyl)phenyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide
-
-
N-(4-chlorobenzyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide
-
-
N-(4-chlorophenyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl)amino)acetamide
-
-
N-(tert-butyl)-2-((2-hydroxy-3-(1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)propyl)(methyl) amino)acetamide
-
-
N-acetyl-D-glucosamine
-
-
N1-(2-bromophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
39.9% inhibition at 0.3 mg/ml
N1-(2-chlorophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
46.7% inhibition at 0.3 mg/ml
N1-(2-fluorophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
48.9% inhibition at 0.3 mg/ml
N1-(2-methoxyphenyl)-N4-(2-oxo-12,3,4-tetrahydroquinolin-3-yl) fumaramide
-
82.3% inhibition at 0.3 mg/ml
N1-(2-nitrophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
53.3% inhibition at 0.3 mg/ml
N1-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-N4-(p-tolyl)fumaramide
-
58.7% inhibition at 0.3 mg/ml
N1-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-N4-phenylfumaramide
-
35.7% inhibition at 0.3 mg/ml
N1-(3,4-difluorophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
66.5% inhibition at 0.3 mg/ml
N1-(3,5-dimethylphenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
71.5% inhibition at 0.3 mg/ml
N1-(3-bromophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
45.2% inhibition at 0.3 mg/ml
N1-(3-nitrophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
49.3% inhibition at 0.3 mg/ml
N1-(4-bromophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
40.3% inhibition at 0.3 mg/ml
N1-(4-chlorophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
50.5% inhibition at 0.3 mg/ml
N1-(4-fluorophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
51.2% inhibition at 0.3 mg/ml
N1-(4-methoxyphenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
74.6% inhibition at 0.3 mg/ml
N1-(4-nitrophenyl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
65.2% inhibition at 0.3 mg/ml
N1-(naphthalen-1-yl)-N4-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl) fumaramide
-
27.8% inhibition at 0.3 mg/ml
NaCl
-
0.5 M, 86% inhibition of Chs1 and 29% inhibition of Chs2
Nikkomycin
nikkomycin X
-
-
nikkomycin Z
Nystatin
-
-
O-methyl pisiferic acid
oudemansin B
-
0.25 mM, 31% inhibition
Pentachlorophenol
-
0.25 mM, 67% inhibition
Polyoxin B
Polyoxin D
polyoxin L
Primulin
-
noncompetitive
SO42-
-
10 mM
strobilurin A
-
0.25 mM, 24% inhibition
strobilurin B
-
0.25 mM, 29% inhibition
terpenoyl benzimidazole
-
weak
UDPgalacturonic acid
-
1 mM, about 20% inhibition
UDPglucose
-
1 mM, about 20% inhibition
UDPglucuronic acid
-
1 mM, about 20% inhibition
UDPmannose
-
1 mM, about 20% inhibition
UDPxylose
-
1 mM, about 20% inhibition
UMP
-
6.25 mM
uracil polyoxin C methyl ester
[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-carbamic acid 2-[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethylcarbamoyloxy]-ethyl ester
-
1 mM, 32% inhibition, competitive. IC50: 2.2 mM
[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl]-carbamic acid 2-{2-[5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethylcarbamoyloxy]-ethoxy}-ethyl ester
-
1 mM 45% inhibition. IC50: 11.8 mM
additional information
-